155 related articles for article (PubMed ID: 16496277)
1. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.
Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P
Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277
[TBL] [Abstract][Full Text] [Related]
2. No influence of immunosuppression on insulin sensitivity and beta-cell function in living donor liver transplantation.
Stockmann M; Nolting S; Konrad T; Hünerbein D; Döbling H; Steinmüller T; Neuhaus P
Transplant Proc; 2005 May; 37(4):1861-4. PubMed ID: 15919486
[TBL] [Abstract][Full Text] [Related]
3. Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation.
Tietge UJ; Selberg O; Kreter A; Bahr MJ; Pirlich M; Burchert W; Müller MJ; Manns MP; Böker KH
Liver Transpl; 2004 Aug; 10(8):1030-40. PubMed ID: 15390330
[TBL] [Abstract][Full Text] [Related]
4. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of postprandial hyperglycemia in liver transplant recipients: comparison of liver transplant patients with kidney transplant patients and healthy controls.
Schneiter P; Gillet M; Chioléro R; Jéquier E; Mosimann F; Temler E; Téta D; Matter M; Wauters JP; Tappy L
Diabetes Metab; 2000 Feb; 26(1):51-6. PubMed ID: 10705104
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus after living donor liver transplantation: data from mainland China.
Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
[TBL] [Abstract][Full Text] [Related]
7. Quantitative liver function tests in donors and recipients of living donor liver transplantation.
Jochum C; Beste M; Penndorf V; Farahani MS; Testa G; Nadalin S; Malago M; Broelsch CE; Gerken G
Liver Transpl; 2006 Apr; 12(4):544-9. PubMed ID: 16482561
[TBL] [Abstract][Full Text] [Related]
8. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
Cottrell DA
J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in the United States.
Qiu J; Ozawa M; Terasaki PI
Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
[TBL] [Abstract][Full Text] [Related]
10. Impact of cyclosporine and low-dose steroid therapy on insulin sensitivity and beta-cell function in patients with long-term liver grafts.
Konrad T; Markus B; Allers C; Vicini P; Toffolo G; Lakos C; Viehmann K; Hanisch E; Encke A; Cobelli C; Usadel KH
Transpl Int; 2001; 14(1):6-11. PubMed ID: 11263561
[TBL] [Abstract][Full Text] [Related]
11. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
[TBL] [Abstract][Full Text] [Related]
12. Minimal model analysis in nondiabetic renal transplant recipients with hepatitis C.
López R; Gentil MA; Acosta D; Escobar MJ; Sánchez F; Pereira P; Algarra GR; Astorga R
Transplant Proc; 2005 Apr; 37(3):1446-8. PubMed ID: 15866633
[TBL] [Abstract][Full Text] [Related]
13. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation.
Moray G; Sevmis S; Karakayali FY; Gorur SK; Haberal M
Transplant Proc; 2006 Dec; 38(10):3572-5. PubMed ID: 17175334
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
Cagnacci A; Ferrari S; Tirelli A; Zanin R; Volpe A
Contraception; 2009 Feb; 79(2):111-6. PubMed ID: 19135567
[TBL] [Abstract][Full Text] [Related]
17. Do graft type or donor source affect acute rejection rates after liver transplant: a multivariate analysis.
Nguyen TH; Melancon K; Lake J; Payne W; Humar A
Clin Transplant; 2008; 22(5):624-9. PubMed ID: 18459996
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
19. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
Humar A; Beissel J; Crotteau S; Kandaswamy R; Lake J; Payne W
Transplantation; 2008 May; 85(10):1420-4. PubMed ID: 18497681
[TBL] [Abstract][Full Text] [Related]
20. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
